Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

B-type natriuretic peptide (BNP) is more sensitive to rapid hemodynamic changes in acute heart failure than N-terminal proBNP.

Mair J, Falkensammer G, Poelzl G, Hammerer-Lercher A, Griesmacher A, Pachinger O.

Clin Chim Acta. 2007 Apr;379(1-2):163-6. Epub 2007 Jan 3.

PMID:
17258185
2.

Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.

Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP.

J Am Coll Cardiol. 2005 May 17;45(10):1667-71.

3.

NT-ProBNP in acute heart failure: correlation with invasively measured hemodynamic parameters during recompensation.

Knebel F, Schimke I, Pliet K, Schattke S, Martin S, Borges AC, Baumann G.

J Card Fail. 2005 Jun;11(5 Suppl):S38-41.

PMID:
15948099
4.

Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.

Alibay Y, Beauchet A, El Mahmoud R, Schmitt C, Brun-Ney D, Benoit MO, Dubourg O, Boileau C, Jondeau G, Puy H.

Biomed Pharmacother. 2005 Jan-Feb;59(1-2):20-4. Epub 2005 Jan 20.

PMID:
15740931
5.

Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure.

Miller WL, Hartman KA, Burritt MF, Borgeson DD, Burnett JC Jr, Jaffe AS.

Clin Chem. 2005 Mar;51(3):569-77. Epub 2004 Dec 22. Erratum in: Clin Chem. 2005 Apr;51(4):798.

6.

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.

Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Cohn JN; Val-HeFT Investigators.

Clin Chem. 2006 Aug;52(8):1528-38. Epub 2006 Jun 15.

7.

High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.

Bruins S, Fokkema MR, Römer JW, Dejongste MJ, van der Dijs FP, van den Ouweland JM, Muskiet FA.

Clin Chem. 2004 Nov;50(11):2052-8. Epub 2004 Sep 2.

8.

Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.

Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L.

Clin Biochem. 2006 Jun;39(6):640-5. Epub 2006 Mar 3.

PMID:
16516185
9.

Pro-B-type natriuretic peptide levels in acute decompensated heart failure.

Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.

J Am Coll Cardiol. 2008 May 13;51(19):1874-82. doi: 10.1016/j.jacc.2007.12.051.

10.
11.

Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.

Tsutamoto T, Sakai H, Nishiyama K, Tanaka T, Fujii M, Yamamoto T, Horie M.

Circ J. 2007 Dec;71(12):1873-8.

12.

B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.

Bal L, Thierry S, Brocas E, Van de Louw A, Pottecher J, Hours S, Moreau MH, Perrin Gachadoat D, Tenaillon A.

Acta Anaesthesiol Scand. 2006 Mar;50(3):340-7.

PMID:
16480468
13.

N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.

Meyer B, Huelsmann M, Wexberg P, Delle Karth G, Berger R, Moertl D, Szekeres T, Pacher R, Heinz G.

Crit Care Med. 2007 Oct;35(10):2268-73.

PMID:
17717488
14.

B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure.

Gegenhuber A, Mueller T, Dieplinger B, Poelz W, Pacher R, Haltmayer M.

Clin Chim Acta. 2006 Aug;370(1-2):174-9. Epub 2006 Mar 6.

PMID:
16600203
15.

Analysis of N-terminal pro-B-type natriuretic peptide and cardiac index in multiple injured patients: a prospective cohort study.

Kirchhoff C, Leidel BA, Kirchhoff S, Braunstein V, Bogner V, Kreimeier U, Mutschler W, Biberthaler P.

Crit Care. 2008;12(5):R118. doi: 10.1186/cc7013. Epub 2008 Sep 12.

16.

Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease.

Mueller T, Gegenhuber A, Poelz W, Haltmayer M.

Clin Chim Acta. 2004 Mar;341(1-2):41-8.

PMID:
14967157
17.

[Non-radioimmunometric NT-ProBNP and BNP assays: impact of diluent, age, gender, BMI].

Alibay Y, Schmitt C, Beauchet A, Dubourg O, Alexandre JA, Boileau C, Jondeau G, Puy H.

Ann Biol Clin (Paris). 2005 Jan-Feb;63(1):43-9. French.

18.
19.

[Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].

El Mahmoud R, Alibay Y, Brun-Ney D, Boulard JC, Dubourg O, Puy H, Jondeau G.

Arch Mal Coeur Vaiss. 2006 Mar;99(3):201-7. French.

PMID:
16618022
20.

[Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].

Zhang SR, Zhang YH, Xu Q, Qiu HX, Chen Q.

Zhongguo Dang Dai Er Ke Za Zhi. 2009 Jun;11(6):429-32. Chinese.

PMID:
19558803

Supplemental Content

Support Center